Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated:  1/11/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated: 1/11/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated:  1/11/2016
Georgetown University Medical Center
mi
from
Washington,
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated: 1/11/2016
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated:  1/11/2016
Morton Plant Hospital
mi
from
Clearwater, FL
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated: 1/11/2016
Morton Plant Hospital
mi
from
Clearwater, FL
Click here to add this to my saved trials
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated:  1/11/2016
St. Anthony's Hospital
mi
from
St. Petersburg, FL
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated: 1/11/2016
St. Anthony's Hospital
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated:  1/11/2016
Georgia Esoteric and Molecular Labs, LLC
mi
from
Augusta, GA
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated: 1/11/2016
Georgia Esoteric and Molecular Labs, LLC
mi
from
Augusta, GA
Click here to add this to my saved trials
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated:  1/11/2016
Woman's Hospital
mi
from
Flowood, MS
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Status: Enrolling
Updated: 1/11/2016
Woman's Hospital
mi
from
Flowood, MS
Click here to add this to my saved trials
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated:  1/11/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated: 1/11/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated:  1/11/2016
Georgetown University Medical Center
mi
from
Washington,
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated: 1/11/2016
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated:  1/11/2016
Morton Plant Hospital
mi
from
Clearwater, FL
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated: 1/11/2016
Morton Plant Hospital
mi
from
Clearwater, FL
Click here to add this to my saved trials
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated:  1/11/2016
St. Anthony's Hospital
mi
from
St. Petersburg, FL
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated: 1/11/2016
St. Anthony's Hospital
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated:  1/11/2016
Georgia Esoteric and Molecular Labs, LLC
mi
from
Augusta, GA
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated: 1/11/2016
Georgia Esoteric and Molecular Labs, LLC
mi
from
Augusta, GA
Click here to add this to my saved trials
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated:  1/11/2016
Woman's Hospital
mi
from
Flowood, MS
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Status: Enrolling
Updated: 1/11/2016
Woman's Hospital
mi
from
Flowood, MS
Click here to add this to my saved trials
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
Status: Enrolling
Updated:  1/11/2016
Mayo Clinic
mi
from
Jacksonville, FL
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer
Status: Enrolling
Updated: 1/11/2016
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family
Comparison of Biomarker Modulation by Inhibition of EGFR and/or Src Family Kinases Using Erlotinib and Dasatinib in Head and Neck Lung Cancers
Status: Enrolling
Updated:  1/12/2016
Hillman Cancer Center
mi
from
Pittsburgh, PA
Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family
Comparison of Biomarker Modulation by Inhibition of EGFR and/or Src Family Kinases Using Erlotinib and Dasatinib in Head and Neck Lung Cancers
Status: Enrolling
Updated: 1/12/2016
Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
Status: Enrolling
Updated:  1/12/2016
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
Status: Enrolling
Updated: 1/12/2016
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
Status: Enrolling
Updated:  1/12/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
Status: Enrolling
Updated: 1/12/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring
Koning Breast CT (KBCT)-Guided Neoadjuvant Treatment of Breast Cancer Monitoring Phase I Trial
Status: Enrolling
Updated:  1/12/2016
University of Rochester Medical Center, Highland Breast Imaging Center
mi
from
Rochester, NY
Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring
Koning Breast CT (KBCT)-Guided Neoadjuvant Treatment of Breast Cancer Monitoring Phase I Trial
Status: Enrolling
Updated: 1/12/2016
University of Rochester Medical Center, Highland Breast Imaging Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Enhancing Exercise in Breast Cancer Survivors
Enhancing Exercise in Breast Cancer Survivors
Status: Enrolling
Updated:  1/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Enhancing Exercise in Breast Cancer Survivors
Enhancing Exercise in Breast Cancer Survivors
Status: Enrolling
Updated: 1/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Yoga for Aromatase Inhibitor-associated Joint Pain
Evaluating Yoga for Aromatase Inhibitor-associated Joint Pain in Women With Breast Cancer: A Pilot Study
Status: Enrolling
Updated:  1/12/2016
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Yoga for Aromatase Inhibitor-associated Joint Pain
Evaluating Yoga for Aromatase Inhibitor-associated Joint Pain in Women With Breast Cancer: A Pilot Study
Status: Enrolling
Updated: 1/12/2016
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Phase II Evaluation of Real-Time, Pharmacokinetically Guided Everolimus in Patients With Hormone Receptor Positive Breast Cancer, Pancreatic Neuroendocrine Tumors (PNET), and Renal Cell Carcinoma
Status: Enrolling
Updated:  1/12/2016
Emory University Hospital Midtown
mi
from
Atlanta, GA
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Phase II Evaluation of Real-Time, Pharmacokinetically Guided Everolimus in Patients With Hormone Receptor Positive Breast Cancer, Pancreatic Neuroendocrine Tumors (PNET), and Renal Cell Carcinoma
Status: Enrolling
Updated: 1/12/2016
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Phase II Evaluation of Real-Time, Pharmacokinetically Guided Everolimus in Patients With Hormone Receptor Positive Breast Cancer, Pancreatic Neuroendocrine Tumors (PNET), and Renal Cell Carcinoma
Status: Enrolling
Updated:  1/12/2016
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Phase II Evaluation of Real-Time, Pharmacokinetically Guided Everolimus in Patients With Hormone Receptor Positive Breast Cancer, Pancreatic Neuroendocrine Tumors (PNET), and Renal Cell Carcinoma
Status: Enrolling
Updated: 1/12/2016
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated:  1/12/2016
University of California, San Diego
mi
from
San Diego, CA
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated: 1/12/2016
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated:  1/12/2016
Rush University Medical Center
mi
from
Chicago, IL
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated: 1/12/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated:  1/12/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated: 1/12/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated:  1/12/2016
Indiana University Medical Center
mi
from
Indianapolis, IN
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated: 1/12/2016
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated:  1/12/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated: 1/12/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated:  1/12/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated: 1/12/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated:  1/12/2016
Baylor University Medical Center
mi
from
Dallas, TX
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated: 1/12/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated:  1/12/2016
Digestive Health Specialists of Tyler, Texas
mi
from
Tyler, TX
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated: 1/12/2016
Digestive Health Specialists of Tyler, Texas
mi
from
Tyler, TX
Click here to add this to my saved trials
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated:  1/12/2016
University Hospital Brno
mi
from
Brno,
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Status: Enrolling
Updated: 1/12/2016
University Hospital Brno
mi
from
Brno,
Click here to add this to my saved trials
Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration
Comparison of Novel PET/CT Imaging Agents and MRS/MRI in Metastatic and High Risk Prostate Cancer: An Inter-SPORE Collaboration
Status: Enrolling
Updated:  1/12/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration
Comparison of Novel PET/CT Imaging Agents and MRS/MRI in Metastatic and High Risk Prostate Cancer: An Inter-SPORE Collaboration
Status: Enrolling
Updated: 1/12/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Identification and Semi -Quantification of ER/PR Proteins Expression
Identification and Semi -Quantification of ER/PR Proteins Expression Status in Formalin Fixed, Paraffin-embedded Normal and Neoplastic Tissue
Status: Enrolling
Updated:  1/12/2016
Scott & White Hospital
mi
from
Temple, TX
Identification and Semi -Quantification of ER/PR Proteins Expression
Identification and Semi -Quantification of ER/PR Proteins Expression Status in Formalin Fixed, Paraffin-embedded Normal and Neoplastic Tissue
Status: Enrolling
Updated: 1/12/2016
Scott & White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCC's With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated:  1/13/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCC's With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated: 1/13/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCC's With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated:  1/13/2016
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
mi
from
New York, NY
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCC's With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated: 1/13/2016
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
A Phase II Randomized, Double-Blind, Vehicle-Controlled, Crossover Clinical Trial of Tazarotene 0.1% and Vehicle Cream Each Applied Once-Daily for 12 or 24 Months in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated:  1/13/2016
Children's Hospital Oakland Research Institute
mi
from
Oakland, CA
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
A Phase II Randomized, Double-Blind, Vehicle-Controlled, Crossover Clinical Trial of Tazarotene 0.1% and Vehicle Cream Each Applied Once-Daily for 12 or 24 Months in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated: 1/13/2016
Children's Hospital Oakland Research Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
A Phase II Randomized, Double-Blind, Vehicle-Controlled, Crossover Clinical Trial of Tazarotene 0.1% and Vehicle Cream Each Applied Once-Daily for 12 or 24 Months in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated:  1/13/2016
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
mi
from
New York, NY
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
A Phase II Randomized, Double-Blind, Vehicle-Controlled, Crossover Clinical Trial of Tazarotene 0.1% and Vehicle Cream Each Applied Once-Daily for 12 or 24 Months in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated: 1/13/2016
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
A Phase II Randomized, Double-Blind, Vehicle-Controlled, Crossover Clinical Trial of Tazarotene 0.1% and Vehicle Cream Each Applied Once-Daily for 12 or 24 Months in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated:  1/13/2016
Children's Hospital Oakland Research Institiute
mi
from
Oakland, CA
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
A Phase II Randomized, Double-Blind, Vehicle-Controlled, Crossover Clinical Trial of Tazarotene 0.1% and Vehicle Cream Each Applied Once-Daily for 12 or 24 Months in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling
Updated: 1/13/2016
Children's Hospital Oakland Research Institiute
mi
from
Oakland, CA
Click here to add this to my saved trials
CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors
Phase I Study of Vaccination With CpG 7909 and Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein in Patients With NY-ESO-1-expressing Tumors
Status: Enrolling
Updated:  1/13/2016
Hillman Cancer Center
mi
from
Pittsburgh, PA
CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors
Phase I Study of Vaccination With CpG 7909 and Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein in Patients With NY-ESO-1-expressing Tumors
Status: Enrolling
Updated: 1/13/2016
Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Medical and Surgical Specialists, LLC
mi
from
Galesburg, IL
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Medical and Surgical Specialists, LLC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Cancer Care Center of Southern Indiana
mi
from
Bloomington, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Cancer Care Center of Southern Indiana
mi
from
Bloomington, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Oncology Hematology Associates of SW Indiana
mi
from
Evansville, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Oncology Hematology Associates of SW Indiana
mi
from
Evansville, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Fort Wayne Oncology & Hematology, Inc
mi
from
Fort Wayne, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Fort Wayne Oncology & Hematology, Inc
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Quality Cancer Center (MCGOP)
mi
from
Indianapolis, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Quality Cancer Center (MCGOP)
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Community Regional Cancer Center
mi
from
Indianapolis, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Community Regional Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Arnett Cancer Care
mi
from
Lafayette, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Arnett Cancer Care
mi
from
Lafayette, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Horizon Oncology Center
mi
from
Lafayette, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Horizon Oncology Center
mi
from
Lafayette, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Medical Consultants, P.C.
mi
from
Muncie, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Medical Consultants, P.C.
mi
from
Muncie, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/13/2016
Methodist Cancer Center
mi
from
Omaha, NE
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/13/2016
Methodist Cancer Center
mi
from
Omaha, NE
Click here to add this to my saved trials